We further delineate the applicability of HyPro labeling as a potentially powerful tool to investigate the molecular principles that contribute to the deregulation of NEAT1 transcripts in cancer and promote NEAT1-dependent tumourigenesis. The gene discussed is NEAT1; the disease is cancer.